

Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics
Market


Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report

Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Growth
Polymerase Chain Reaction (PCR) technology for Point-of-Care (POC) diagnostics has witnessed significant growth in recent years due to its rapid and accurate testing capabilities. The global PCR for POC Diagnostics market size is estimated to be valued at $XX billion in 2021 and is expected to grow at a CAGR of XX% during the forecast period.

Request Sample Report

Companies Covered
(Covid 19 Impact Covered)
◍ Abbott Laboratories
◍ Atlas Genetics
◍ Cepheid
◍ Fluxergy
◍ Roche Diagnostics

Competitive Landscape:
- Abbott Laboratories, Atlas Genetics, Cepheid, Fluxergy, and Roche Diagnostics are key players in the PCR for POC diagnostics market.
- These companies leverage PCR technology to offer rapid, accurate, and portable diagnostic solutions for various infectious diseases.
- They contribute to market growth by developing innovative PCR-based POC devices.
Sales Revenue (in million USD):
- Abbott Laboratories: $34.63 billion
- Cepheid: $618.2 million
- Roche Diagnostics: $16.75 billion
Request Sample Report


Market Segmentation
By Application
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Request Sample Report
By Product
Real Time PCR
DNA/RNA Purification


Market Growth

Request Sample Report
$ X Billion USD












